Skip to main content

Table 3 Measurements at baseline and 12 weeks follow-up (n = 11)

From: Adherence to self-managed exercises for patients with persistent subacromial pain: the Ad-Shoulder feasibility study

 

SPADI week 0/12

PSFS week 0/12

NPRS week 0/12

Kinesiophobia week 0/12

WAI week 0/12

Self-Efficacy week 0/12

PSEQ-2 week 0/12

BIS week 0/12

EQ5D-5L week 0/12

Physical activity week 0/6/12

GPE week 12

Case 1

56/3

5/9.7

5/0

1/1

5/9

4/1

9/12

22/13

0.67/1

37/48/23

1

Case 2

19/0

2.7/10

5/0

6/0

10/10

2/1

12/12

6/0

0.82/1

31/-/52

1

Case 3

67/46

0.3/2.3

9/6

2/1

4/7

5/5

7/7

35/32

0.73/0.52

58/-/-

4

Case 4

43/32

3/5.3

7/3

7/4

9/10

2/2

9/11

9/11

0.73/0.75

293/358/215

3

Case 5

20/5

6.3/6.3

3/1

5/1

10/10

2/2

11/11

10/4

0.86/0.86

120/-/217

2

Case 6

57/21

8.7/8.3

8/2

8/7

7/8

3/2

9/8

25/16

0.59/0.73

217/323/323

2

Case 7

19/5

6.3/7.7

3/1

7/1

8/9

4/2

11/10

10/4

0.79/0.86

216/204/158

3

Case 8

22/23

2.7/3.3

2/3

0/0

5/6

2/1

12/11

7/2

0.64/0.82

343/617/348

3

Case 9

38/22

3.3/7.3

5/3

2/2

6/7

3/2

9/9

12/6

0.67/0.79

120/137/202

2

Case 10

22/3

5/10

2/0

0/0

10/10

2/1

12/12

10/9

0.86/1

132/84/41

1

Case 11

65/-

7/-

6/-

7/-

7/-

4/-

8/-

14/-

0.73/-

110/-/-

-

Median (range)

38 (19–67)/21 (0–46)

3.3 (0.3–8.7)/8 (2.3–10)

5 (2–9)/2 (0–6)

3.5 (0–8)/1 (0–7)

7 (0–10)/9 (6–10)

2.5 (2–5)/2 (1–5)

9 (7–12)/11 (7–12)

10 (6–35)/6 (2–32)

0.73 (0.59–0.86)/0.84 (0.52–1)

132 (31–343)/170 (48–617)/158 (23–323)

2 (1–4)

Median change week 0/12 (n = 10)

18 (− 1 to 53)

2.2 (− 0.4 to 7.33)

2.5 (− 1 to 6)

1 (0–6)

1 (0–4)

1 (0–3)

0 (− 1 to 3)

6(− 2 to 9)

0.13 (− 0.21 to 0.33)

14 (− 91 to 107)

-

Missing data

-/1

-/1

-/1

-/1

-/1

-/1

-/1

-/1

-/1

-/4/2

1

Floor effect*

-

-

-

-

-

-

-

-

-

-

-

Ceiling effect**

-

-

-

2

3

-

3

-

-

-

-

  1. SPADI, Shoulder Pain and Disability Index (0–100, 100 worst score); PSFS, Patient Specific Function Scale (0–10, 0 = unable to perform activity); NPRS, Numeric pain rating scale (0–10, 10 = most intense pain imaginable); Kinesiophobia (0–10, 10 = very much fear); PSEQ2, Pain Self-Efficacy Questionnaire 2 item (0–12, 0 = not at all confident); Self-efficacy, “How confident have you felt about managing your shoulder pain by yourself” (1–5, 5 = not at all confident); BIS, Bergen Insomnia Scale, 0–42 (42 = worst score); WAI, Working Ability Index, 0–10 (0 = cannot work at all); EQ5D-5L, 1 = perfect health; physical activity, minutes of moderate physical activity (MET ≥ 3) during three consecutive days measured using an accelerometer; GPE, global perceived effect scale, 1–6, 1 = very much better, 6 = very much worse
  2. *Number of patients with the worst score at baseline
  3. **Number of patients with the best score at baseline